![](/img/cover-not-exists.png)
PSS2 THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS
Lozano-Ortega, G., Rogula, B., Gaudet, V., Mickle, A., Johnston, K., Barbeau, M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1774
Date:
May, 2019
File:
PDF, 384 KB
2019